(Q36605959)

15 August 2017

1 reference

title

Titrating graft-versus-host disease: is it worth a try? (English)

1 reference

15 August 2017

Akpek G

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

25 September 2006

1 reference

Bone Marrow Transplantation

15 August 2017

published in

1 reference

15 August 2017

volume

38

1 reference

15 August 2017

issue

10

1 reference

15 August 2017

page(s)

653-656

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705504

15 August 2017

exact match

0 references

cites work

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

Pathophysiology and treatment of graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

Prophylaxis and treatment of acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

Dissociation of putative graft‐versus‐haematopoiesis and graft‐versus‐myeloma effects in patients with rapidly progressive multiple myeloma*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

Molecules and mechanisms of the graft-versus-leukaemia effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

Optimizing engraftment--source and dose of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

Graft versus Host Reaction modified by in vitro Marrow–Erythrocyte Preincubation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

Graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

7 January 2021

Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

7 January 2021

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

7 January 2021

Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

7 January 2021

The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

7 January 2021

New developments in allotransplant immunology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705504

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705504

1 reference

Dimensions Publication ID

15 August 2017

1044128300

0 references

1 reference